Tablet having a two-dimensional identifier
Inventors
Kühne, Klaus • KERSCHBAUMER, Helmut • Moldenhauer, Daniel • Ruckdäschel, Alexander • Schneeberger, Achim
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
A solid dosage form for active ingredient release can be a preparation for medical, dental or cosmetic purposes, and is preferably a tablet. The solid dosage form comprises a three-dimensional base body which comprises an active ingredient. The solid dosage form further comprises a portion having a structure forming a two-dimensional identifier, such as, for instance, a QR code.
Core Innovation
The invention relates to a solid dosage form for active ingredient release, in particular a tablet, comprising a three-dimensional base body with an active ingredient. The tablet further comprises a portion having a structure forming a two-dimensional identifier, and the portion is integral with the three-dimensional base body, so that the identifier structure is formed as part of the tablet rather than as a separate added element.
A central objective addressed is improving unambiguous authentication while increasing medicament safety. Compared with prior approaches that use punching tablets and separately printed, easily damaged two-dimensional codes, the integral portion is described as being less easy to remove. The patent emphasizes that authentication can be supported by a two-dimensional identifier such as a QR code, barcode, or haptic code that remains associated with the medicament.
The patent also describes forming the portion by screen printing, including providing a first printing paste comprising an active ingredient and applying it by means of a first printing screen. A second printing paste comprising a colouring agent is then applied by means of a second printing screen to form a portion whose structure forms the two-dimensional identifier, where the pattern of the second printing screen defines the structure. The portion can be configured on a surface, as a protrusion or planar structure, or enclosed, and the identifier is described as readable in different ways including by eyes, haptics, or smartphone camera, with optional detectability after administration using a detectable marker.
Claims Coverage
The document provides two independent claims. The independent claims cover an integral tablet portion forming a two-dimensional identifier and a screen-printing production method using two pastes to form that identifier portion.
Integral two-dimensional identifier portion on an active-ingredient tablet
A solid dosage form for active ingredient release, in a tablet comprising a three-dimensional base body with an active ingredient, and a portion integral with the three-dimensional base body, the portion having a structure forming a two-dimensional identifier.
Two-paste screen printing forming a two-dimensional identifier portion
A method for production by means of screen printing of a dosage form, comprising providing a first printing paste comprising an active ingredient and applying it by means of a first printing screen, providing a second printing paste comprising a colouring agent and applying it by means of a second printing screen to form a portion of the dosage form having a structure forming a two-dimensional identifier, wherein a pattern of the second printing screen defines a structure of the portion.
Overall, the claims focus on an integral tablet portion that structurally forms a two-dimensional identifier and on a screen-printing method using first and second printing pastes, where the second printing screen pattern defines the two-dimensional identifier portion.
Stated Advantages
Improved unambiguous authentication of the medicament.
Increased medicament safety because the two-dimensional identifier cannot be easily removed.
Documented Applications
Authentication of a medicament using an integrated two-dimensional identifier on an active-ingredient tablet.
Detectability after administration using a marker and imaging methods, including the concept of imaging-based detection after administration.
Interested in licensing this patent?